BioCentury | May 13, 2013
Company News

Ilika, Regenerys deal

...Regenerative medicine company Regenerys acquired Ilika's Altrika Ltd. subsidiary in Sheffield, U.K. Altrika markets its cell-based...
...for breast reconstruction following surgery for cancer. The companies could not be reached for details. Ilika plc...
BioCentury | Oct 29, 2012
Company News

Ilika, University of Edinburgh deal

...The university granted materials R&D company Ilika an exclusive, worldwide license to use the university's heat-sensitive...
...and bioreactors, to release cells using only temperature control. The companies declined to disclose details. Ilika plc...
BioCentury | Sep 29, 2008
Product Development

Ophthalmic deals

...for retinal dystrophies using targets selected by Fovea and Genzyme's gene delivery technologies Nov 07 CellTran/Ilika...
BioCentury | Nov 19, 2007
Company News

CellTran, Ilika Technologies Ltd. deal

...CellTran and Ilika partnered to develop CellTran's corneal stem cell therapy delivered using plasma polymerization technology...
...The therapy is expected to start Phase I testing to treat corneal damage next year. Ilika...
...will be responsible for commercialization. Further terms were not disclosed. CellTran Ltd. , Sheffield, U.K. Ilika...
Items per page:
1 - 4 of 4
BioCentury | May 13, 2013
Company News

Ilika, Regenerys deal

...Regenerative medicine company Regenerys acquired Ilika's Altrika Ltd. subsidiary in Sheffield, U.K. Altrika markets its cell-based...
...for breast reconstruction following surgery for cancer. The companies could not be reached for details. Ilika plc...
BioCentury | Oct 29, 2012
Company News

Ilika, University of Edinburgh deal

...The university granted materials R&D company Ilika an exclusive, worldwide license to use the university's heat-sensitive...
...and bioreactors, to release cells using only temperature control. The companies declined to disclose details. Ilika plc...
BioCentury | Sep 29, 2008
Product Development

Ophthalmic deals

...for retinal dystrophies using targets selected by Fovea and Genzyme's gene delivery technologies Nov 07 CellTran/Ilika...
BioCentury | Nov 19, 2007
Company News

CellTran, Ilika Technologies Ltd. deal

...CellTran and Ilika partnered to develop CellTran's corneal stem cell therapy delivered using plasma polymerization technology...
...The therapy is expected to start Phase I testing to treat corneal damage next year. Ilika...
...will be responsible for commercialization. Further terms were not disclosed. CellTran Ltd. , Sheffield, U.K. Ilika...
Items per page:
1 - 4 of 4